RNA Vaccines
Editat de Thomas Kramps, Knut Elbersen Limba Engleză Paperback – 7 iul 2018
Authoritative and cutting-edge, RNA Vaccines: Methods and Protocols aims to increased collaboration on RNA vaccines between basic and applied scientists in academia, government, and industry to develop future solutions for today’s challenges.
Preț: 746.83 lei
Preț vechi: 786.14 lei
-5%
Puncte Express: 1120
Carte tipărită la comandă
Livrare economică 03-17 octombrie
Livrare prin curier în România Termenul estimat este afișat lângă disponibilitate.
Transport gratuit pentru acest produs Plată online sau ramburs, în funcție de opțiunile comenzii.
Retur gratuit în 14 zile Comandă securizată și suport în română.
Specificații
ISBN-13: 9781493982141
ISBN-10: 1493982141
Pagini: 296
Ilustrații: XI, 282 p. 42 illus., 26 illus. in color.
Dimensiuni: 178 x 254 x 17 mm
Greutate: 0.56 kg
Ediția:Softcover reprint of the original 1st edition 2017
Editura: Humana
Locul publicării:New York, NY, United States
ISBN-10: 1493982141
Pagini: 296
Ilustrații: XI, 282 p. 42 illus., 26 illus. in color.
Dimensiuni: 178 x 254 x 17 mm
Greutate: 0.56 kg
Ediția:Softcover reprint of the original 1st edition 2017
Editura: Humana
Locul publicării:New York, NY, United States
Cuprins
Introduction to RNA Vaccines.- Self-replicating RNA.- Self-replicating RNA Vaccine Delivery to Dendritic Cells.- Plant Expression of Trans-encapsidated Viral Nanoparticle Vaccines with Animal RNA Replicons.- RNActive® Technology: Generation and Testing of Stable and Immunogenic mRNA Vaccines.- Nucleoside Modified mRNA Vaccines for Infectious Diseases.- Generation and Evaluation of Prophylactic mRNA Vaccines against Allergy.- Measuring the Adjuvant Activity of RNA Vaccines.- Generation of Immunostimulating 130 nm Protamine-RNA Nanoparticles.- Electroporation of mRNA as Universal Technology Platform to Transfect a Variety of Primary Cells with Antigens and Functional Proteins.- Adjuvant-Enhanced mRNA Vaccines.- Enhanced Delivery of DNA or RNA Vaccines by Electroporation.- The European Regulatory Environment of RNA-Based Vaccines.- Discovery and Subtyping of Neo-Epitope Specific T-cell Responses for Cancer Immunotherapy: Addressing the Mutanome.- Considerations for Producing mRNA Vaccines for Clinical Trials.- Nonclinical Safety Testing of RNA Vaccines.- Immunotherapy of Uveal Melanoma: Vaccination Against Cancer.
Caracteristici
Includes cutting-edge methods and protocols Provides step-by-step detail essential for reproducible results Contains key notes and implementation advice from the experts Includes supplementary material: sn.pub/extras